Rockefeller University Press

Table I

Demographic and clinical features of patients

Patient  code	Gender/age	Disease  course^{^a}	Clinical  relapses  in 2 yr  before HSCT	Clinical  relapses  after HSCT	Clinical  follow-up  after HSCT
	yr		no.		mo
1	M/53	SP-MS	2	0	36
2	M/30	RR-MS	4	0	28
3	F/53	SP-MS	3	0	28
4	M/28	PR-MS	2	0	28
5	M/45	PR-MS	4	0	27
6	F/47	SP-MS	2	0	25
7	M/51	SP-MS	2	0	21

Patient  code	Gender/age	Disease  course^{^a}	Clinical  relapses  in 2 yr  before HSCT	Clinical  relapses  after HSCT	Clinical  follow-up  after HSCT
	yr		no.		mo
1	M/53	SP-MS	2	0	36
2	M/30	RR-MS	4	0	28
3	F/53	SP-MS	3	0	28
4	M/28	PR-MS	2	0	28
5	M/45	PR-MS	4	0	27
6	F/47	SP-MS	2	0	25
7	M/51	SP-MS	2	0	21

^a

PR-MS, progressive–relapsing MS; RR-MS, relapsing–remitting MS; SP-MS, secondary progressive MS.